Romaric Gérardy

Romaric Gérardy

Auto-generated profile, based on publicly available information

Romaric Gérardy

Center for Integrated Technology and Organic Synthesis, Research Unit MolSys, University of Liège, B-4000 Liège (Sart Tilman), Belgium

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Chemical Reviews
Verified
Journal Article
Closed access
RGRomaric Gérardy
Romaric Gérardy
Damien DebeckerDamien Debecker
Damien Debecker
JEJulien Estager
Julien Estager
PLPatricia Luis
Patricia Luis
JMJean-Christophe M. Monbaliu
Jean-Christophe M. Monbaliu

25 May 2018 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
RGRomaric Gérardy
Romaric Gérardy
NENoémie Emmanuel
Noémie Emmanuel
TTThomas Toupy
Thomas Toupy
VKVictor‐Emmanuel Kassin
Victor‐Emmanuel Kassin
NTNelly Ntumba Tshibalonza
Nelly Ntumba Tshibalonza
JMJean‐Christophe M. Monbaliu
Jean‐Christophe M. Monbaliu

26 November 2018 in Topics in Current Chemistry
Verified
Journal Article
Closed access
PDF file
RGRomaric Gérardy
Romaric Gérardy
RMRomain Morodo
Romain Morodo
JEJulien Estager
Julien Estager
PLPatricia Luis
Patricia Luis
Damien DebeckerDamien Debecker
Damien Debecker
JMJean-Christophe M. Monbaliu
Jean-Christophe M. Monbaliu

27 December 2018 in Organic Process Research & Development
Verified
Journal Article
Closed access
JWJason D. Williams
Jason D. Williams
MNMomoe Nakano
Momoe Nakano
RGRomaric Gérardy
Romaric Gérardy
JRJuan A. Rincón
Juan A. Rincón
ÓFÓscar de Frutos
Óscar de Frutos
CKC. Kappe
C. Kappe

10 July 2019 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
RMRomain Morodo
Romain Morodo
RGRomaric Gérardy
Romaric Gérardy
GPGuillaume Petit
Guillaume Petit
JMJean-Christophe M. Monbaliu
Jean-Christophe M. Monbaliu
A robust continuous flow procedure for the transformation of bio-based glycerol into high value-added oxiranes (epichlorohydrin and glycidol) is presented. The flow procedure features a central hydrochlorination/dechlorination sequence and provides economically and environmentally favorable conditions involving an organocatalyst and aqueous solutions of hydrochloric acid and sodium hydroxide. Pimelic acid (10 mol%) shows an exceptional catalytic activity (>99% conversion of glycerol, a high selectivity toward 1,3-dichloro-2-propanol and 81% cumulated yield toward intermediate chlorohydrins) for the hydrochlorination of glycerol (140 °C) with 36 wt% aqueous HCl. These conditions are validated on a sample of crude bio-based glycerol. The dechlorination step is effective (quantitative conversion based on glycerol) with concentrated aqueous sodium hydroxide (20 °C) and can be directly concatenated to the hydrochlorination step, hence providing a ca. 2 : 3 separable mixture of glycidol and epichlorohydrin (74% cumulated yield). An in-line membrane separation unit is included downstream, providing usable streams of epichlorohydrin (in MTBE, with an optional concentrator) and glycidol (in water). The scalability of the dechlorination step is then assessed in a commercial pilot-scale continuous flow reactor. Next, bio-based epichlorohydrin is further utilized for the continuous flow preparation of β-amino alcohol active pharmaceutical ingredients including propranolol (hypertension, WHO essential), naftopidil (prostatic hyperplasia) and alprenolol (angina pectoris) within a concatenable two-step procedure using a FDA class 3 solvent (DMSO). This work provides the first example of direct upgrading of bio-based glycerol into high value-added pharmaceuticals under continuous flow conditions.

19 March 2019 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
VKVictor-Emmanuel H. Kassin
Victor-Emmanuel H. Kassin
RGRomaric Gérardy
Romaric Gérardy
TTThomas Toupy
Thomas Toupy
DCDiégo Collin
Diégo Collin
ESElena Salvadeo
Elena Salvadeo
JMJean-Christophe M. Monbaliu
Jean-Christophe M. Monbaliu
Continuous flow preparation of antidepressant ketamine and analogs under sustainable conditions.